|
|
Volumn 348, Issue , 2014, Pages
|
|
Two companies blocked from comparing their generic products to Herceptin in India.
a
a
NONE
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOSIMILAR AGENT;
MONOCLONAL ANTIBODY;
TRASTUZUMAB;
COMMERCIAL PHENOMENA;
DRUG APPROVAL;
ECONOMIC ASPECT;
HUMAN;
INDIA;
LEGAL ASPECT;
NOTE;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BIOSIMILAR PHARMACEUTICALS;
COMMERCE;
DRUG APPROVAL;
ECONOMIC COMPETITION;
HUMANS;
INDIA;
|
|
EID: 84900528178
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g1632 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
